Craig Gibson
Associate Director, Global Market Access & Outcomes Research
CELGENE
What are your key priorities in the next 6-12 months?
Supporting global product launch with ex-US reimbursement submissions and publishing evidence differentiating our product from competition.
How do you feel that the pharmaceutical pricing landscape is evolving, and how does this impact your role?
Market access and reimbursement are taking a greater role, especially in markets where they were not previously high hurdles. This is adding visibility to the role and increasing the need for skilled professionals to understand reimbursement implications as early as possible in development.
What has been your greatest achievement or most exciting project in your current role?
Training all regional affiliates on the value story of our products, including the burden of illness, clinical benefits, and economic support.
What are you most looking forward to about the upcoming Pharmaceutical Pricing & Contracting Conference?
Learning from others who are facing similar challenges.
Craig will be one of the distinguished speakers at the Pharmaceutical Pricing & Contracting Conference.
